Real-World Effectiveness and Safety of Antipsychotics in Individuals at Clinical High-Risk for Psychosis: Study Protocol for a Prospective Observational Study (ShangHai at Risk for Psychosis-Phase 2)
GuiSen Wu,1 RanPiao Gan,1 ZhiXing Li,1 LiHua Xu,1 XiaoChen Tang,1 YanYan Wei,1 YeGang Hu,1 HuiRu Cui,1 HuiJun Li,2 YingYing Tang,1 Li Hui,3 XiaoHua Liu,1 ChunBo Li,1 JiJun Wang,1,4,5 TianHong Zhang1 1Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai Key Laborat...
Enregistré dans:
Auteurs principaux: | Wu G, Gan R, Li Z, Xu L, Tang X, Wei Y, Hu Y, Cui H, Li H, Tang Y, Hui L, Liu X, Li C, Wang J, Zhang T |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2019
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/afbae09b9d26423ba25d94701b731b9b |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Characterization of antipsychotic medications, amino acid signatures, and platelet-activating factor in first-episode psychosis
par: Bracha Erlanger Avigdor, et autres
Publié: (2021) -
Antipsychotics and risk of natural death in patients with schizophrenia
par: Chen Y, et autres
Publié: (2019) -
Atypical antipsychotics for Parkinson’s disease psychosis: a systematic review and meta-analysis
par: Zhang H, et autres
Publié: (2019) -
Neuroleptic-induced deficit syndrome in bipolar disorder with psychosis
par: Ueda S, et autres
Publié: (2016) -
The Implementation and Review of Cognitive Remediation Training for First Episode Psychosis in Singapore
par: Nigel Ian Ming Chong, et autres
Publié: (2021)